Cargando…

Effectiveness of Medication Reconciliation in a Chinese Hospital: A Pilot Randomized Controlled Trial

BACKGROUND: Implementing medication reconciliation (MR) was complex and challenging because of the variability in the guidance provided for conducting. The processes of MR adopted in China were different from that recommended by the World Health Organization. A pilot study to inform the design of a...

Descripción completa

Detalles Bibliográficos
Autores principales: Chai, Dongyan, Liu, Zhihui, Wang, Liuyi, Duan, Hongyan, Zhao, Chenglong, Xu, Chengyang, Zhang, Dongyan, Zhao, Qiongrui, Ma, Peizhi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10683647/
https://www.ncbi.nlm.nih.gov/pubmed/38034875
http://dx.doi.org/10.2147/JMDH.S432522
_version_ 1785151242430840832
author Chai, Dongyan
Liu, Zhihui
Wang, Liuyi
Duan, Hongyan
Zhao, Chenglong
Xu, Chengyang
Zhang, Dongyan
Zhao, Qiongrui
Ma, Peizhi
author_facet Chai, Dongyan
Liu, Zhihui
Wang, Liuyi
Duan, Hongyan
Zhao, Chenglong
Xu, Chengyang
Zhang, Dongyan
Zhao, Qiongrui
Ma, Peizhi
author_sort Chai, Dongyan
collection PubMed
description BACKGROUND: Implementing medication reconciliation (MR) was complex and challenging because of the variability in the guidance provided for conducting. The processes of MR adopted in China were different from that recommended by the World Health Organization. A pilot study to inform the design of a future randomized controlled trial to determine the effectiveness of these two workflows was undertaken. METHODS: Patients taking at least one home/regular medication for hypertension, diabetes, or coronary heart disease were recruited at admission, and then were randomized using a computer-generated random number in a closed envelope. In the study group, the pharmacist reviewed electronic medical record systems before communication with patients. In the control group, pharmacists communicated with patients at patient’s admission. The time investment of pharmacists for MR process, the number of unintended medication discrepancies, and physician acceptance were tested as outcome measures. RESULTS: One hundred and forty adult patients were randomized, of which 66 patients in the intervention received MR within 24 hours, while 58 patients in control received MR at some point during admission. The most common condition in the study group was hypertension (coronary heart disease in the control group). The workflow of the study group can save an average 7 minutes per patient compared with the WHO recommended process [17.5 minutes (IQR 14.00, 28.25) vs 24.5 minutes (IQR17.75, 35.25), p = 0.004]. The number of unintended discrepancies was 42 in the study group and 34 in the control group (p = 0.33). Physicians’ acceptance in the study and control groups were 87.5% and 92.3%, respectively (p = 0.87). CONCLUSION: The results suggest that changes in outcome measures were in the appropriate direction and that the time limit for implementing MR can be set within 48 hours. A future multi-centre RCT study to determine the effectiveness of MR is feasible and warranted.
format Online
Article
Text
id pubmed-10683647
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-106836472023-11-30 Effectiveness of Medication Reconciliation in a Chinese Hospital: A Pilot Randomized Controlled Trial Chai, Dongyan Liu, Zhihui Wang, Liuyi Duan, Hongyan Zhao, Chenglong Xu, Chengyang Zhang, Dongyan Zhao, Qiongrui Ma, Peizhi J Multidiscip Healthc Original Research BACKGROUND: Implementing medication reconciliation (MR) was complex and challenging because of the variability in the guidance provided for conducting. The processes of MR adopted in China were different from that recommended by the World Health Organization. A pilot study to inform the design of a future randomized controlled trial to determine the effectiveness of these two workflows was undertaken. METHODS: Patients taking at least one home/regular medication for hypertension, diabetes, or coronary heart disease were recruited at admission, and then were randomized using a computer-generated random number in a closed envelope. In the study group, the pharmacist reviewed electronic medical record systems before communication with patients. In the control group, pharmacists communicated with patients at patient’s admission. The time investment of pharmacists for MR process, the number of unintended medication discrepancies, and physician acceptance were tested as outcome measures. RESULTS: One hundred and forty adult patients were randomized, of which 66 patients in the intervention received MR within 24 hours, while 58 patients in control received MR at some point during admission. The most common condition in the study group was hypertension (coronary heart disease in the control group). The workflow of the study group can save an average 7 minutes per patient compared with the WHO recommended process [17.5 minutes (IQR 14.00, 28.25) vs 24.5 minutes (IQR17.75, 35.25), p = 0.004]. The number of unintended discrepancies was 42 in the study group and 34 in the control group (p = 0.33). Physicians’ acceptance in the study and control groups were 87.5% and 92.3%, respectively (p = 0.87). CONCLUSION: The results suggest that changes in outcome measures were in the appropriate direction and that the time limit for implementing MR can be set within 48 hours. A future multi-centre RCT study to determine the effectiveness of MR is feasible and warranted. Dove 2023-11-24 /pmc/articles/PMC10683647/ /pubmed/38034875 http://dx.doi.org/10.2147/JMDH.S432522 Text en © 2023 Chai et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Chai, Dongyan
Liu, Zhihui
Wang, Liuyi
Duan, Hongyan
Zhao, Chenglong
Xu, Chengyang
Zhang, Dongyan
Zhao, Qiongrui
Ma, Peizhi
Effectiveness of Medication Reconciliation in a Chinese Hospital: A Pilot Randomized Controlled Trial
title Effectiveness of Medication Reconciliation in a Chinese Hospital: A Pilot Randomized Controlled Trial
title_full Effectiveness of Medication Reconciliation in a Chinese Hospital: A Pilot Randomized Controlled Trial
title_fullStr Effectiveness of Medication Reconciliation in a Chinese Hospital: A Pilot Randomized Controlled Trial
title_full_unstemmed Effectiveness of Medication Reconciliation in a Chinese Hospital: A Pilot Randomized Controlled Trial
title_short Effectiveness of Medication Reconciliation in a Chinese Hospital: A Pilot Randomized Controlled Trial
title_sort effectiveness of medication reconciliation in a chinese hospital: a pilot randomized controlled trial
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10683647/
https://www.ncbi.nlm.nih.gov/pubmed/38034875
http://dx.doi.org/10.2147/JMDH.S432522
work_keys_str_mv AT chaidongyan effectivenessofmedicationreconciliationinachinesehospitalapilotrandomizedcontrolledtrial
AT liuzhihui effectivenessofmedicationreconciliationinachinesehospitalapilotrandomizedcontrolledtrial
AT wangliuyi effectivenessofmedicationreconciliationinachinesehospitalapilotrandomizedcontrolledtrial
AT duanhongyan effectivenessofmedicationreconciliationinachinesehospitalapilotrandomizedcontrolledtrial
AT zhaochenglong effectivenessofmedicationreconciliationinachinesehospitalapilotrandomizedcontrolledtrial
AT xuchengyang effectivenessofmedicationreconciliationinachinesehospitalapilotrandomizedcontrolledtrial
AT zhangdongyan effectivenessofmedicationreconciliationinachinesehospitalapilotrandomizedcontrolledtrial
AT zhaoqiongrui effectivenessofmedicationreconciliationinachinesehospitalapilotrandomizedcontrolledtrial
AT mapeizhi effectivenessofmedicationreconciliationinachinesehospitalapilotrandomizedcontrolledtrial